Patients

News

GSK pledges £1bn drive for infectious disease R&D

GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious diseases that mainly impact lower-income countries.

Partner Content

Partner Content

Understanding the True Impact of the COVID-19 Pandemic on th...

Complexities demonstrate the need for more resources

News

Closeup of X-ray photography of human brain

Single MRI-based brain scan could diagnose Alzheimer’s disea...

Alzheimer’s disease could be diagnosed from a single MRI brain scan, according to a new study by Imperial College London.

News

Pharmacy chain Walgreens plans to disrupt clinical trial sec...

Walgreens is the latest US retail pharmacy giant to have a go at disrupting the clinical trials industry, with the launch of a new business unit that will tap into its reserve of patient da

Views & Analysis

close up of a prescription bottle with white tables falling out on top of a group of hundred dollar bills

How celebrity investor Mark Cuban is tackling out-of-control...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that

News

UK grants early access to Argenx' efgartigimod for myastheni...

The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG) to get early access to Argenx' efgartigimod while it reviews the marketing applic

GSK pledges £1bn drive for infectious disease R&D

Understanding the True Impact of the COVID-19 Pandemic on th...

Single MRI-based brain scan could diagnose Alzheimer’s disea...

Pharmacy chain Walgreens plans to disrupt clinical trial sec...

How celebrity investor Mark Cuban is tackling out-of-control...

UK grants early access to Argenx' efgartigimod for myastheni...

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

Patients

Editor's Picks